VU Research Portal
Cerebrospinal fluid biomarkers in dementia with Lewy bodies
van Steenoven, I.
2020
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
van Steenoven, I. (2020). Cerebrospinal fluid biomarkers in dementia with Lewy bodies: towards a biological
diagnosis.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
546527-L-bw-Steenoven
546527-L-bw-Steenoven
546527-L-bw-Steenoven
546527-L-bw-Steenoven
Processed on: 4-8-2020
Processed on: 4-8-2020
Processed on: 4-8-2020
Processed on: 4-8-2020
PDF page: 5PDF page: 5PDF page: 5PDF page: 5
TABLE OF CONTENTS
Chapter 1 General Introduction
7
PART 1. Existing cerebrospinal fluid biomarkers in dementia with Lewy bodies
21
Chapter 2
α-Synuclein species as potential cerebrospinal fluid
biomarkers for Dementia with Lewy bodies
23
Chapter 3
CSF AD biomarkers across the spectrum of Lewy body
diseases: Results from a large multicenter cohort
47
Chapter 4
Alzheimer’s disease cerebrospinal fluid biomarkers
predict cognitive decline in Lewy body dementia
67
Chapter 5
Amyloid-β Peptides in cerebrospinal fluid of patients with
dementia with Lewy Bodies
83
PART 2. Novel cerebrospinal fluid biomarkers in dementia with Lewy bodies
105
Chapter 6
Identification of novel cerebrospinal fluid biomarker
candidates for dementia with Lewy bodies: a proteomic
approach
107
Chapter 7
VGF Peptides in Cerebrospinal Fluid of Patients with
dementia with Lewy Bodies
151
Chapter 8 Summary and General discussion
177
Addendum
Nederlandse samenvatting
List of author affiliations
List of publications
Dissertations Alzheimer Center Amsterdam
Portfolio
Dankwoord
About the author
197
206
210
213
217
218
223
